Renaissance Technologies LLC
- SEC CIK
- 0001037389
- Latest filing
- Aug 13, 2026
NKTR holding history
Nektar Therapeutics in every 13F filed by Renaissance Technologies LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NKTR overviewAll 13F holders of NKTRFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 14
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −41,781−100.0% | Sold out | Holders |
| Q1 2026 | 41,781 | $3.01M | <0.1% | −131,100−75.8% | Reduced | Holders |
| Q4 2025 | 172,881 | $7.31M | <0.1% | −105,660−37.9% | Reduced | Holders |
| Q3 2025 | 278,541 | $15.8M | <0.1% | +31,481+12.7% | Added | Holders |
| Q2 2025 | 247,060 | $6.38M | <0.1% | −66,392−21.2% | ReducedConverted for a 1-for-15 split | Holders |
| Q1 2025 | 4,701,781 | $3.20M | <0.1% | +790,995+20.2% | Added | Holders |
| Q4 2024 | 3,910,786 | $3.64M | <0.1% | +583,153+17.5% | Added | Holders |
| Q3 2024 | 3,327,633 | $4.33M | <0.1% | +13,800+0.4% | Added | Holders |
| Q2 2024 | 3,313,833 | $4.11M | <0.1% | −1,306,848−28.3% | Reduced | Holders |
| Q1 2024 | 4,620,681 | $4.32M | <0.1% | −704,794−13.2% | Reduced | Holders |
| Q4 2023 | 5,325,475 | $3.01M | <0.1% | +1,818,794+51.9% | Added | Holders |
| Q3 2023 | 3,506,681 | $2.09M | <0.1% | −585,000−14.3% | Reduced | Holders |
| Q2 2023 | 4,091,681 | $2.35M | <0.1% | +1,087,985+36.2% | Added | Holders |
| Q1 2023 | 3,003,696 | $2.11M | <0.1% | +2,886,585+2,464.8% | Added | Holders |
| Q4 2022 | 117,111 | $265.0K | <0.1% | +117,111 | New | Holders |